That is exactly what we need to fight COVID-19 – a drug that works directly in the lungs
A worldwide health care crisis demands agility and common sense, both in short supply in America these days.
As COVID-19 case numbers and hospitalizations rise throughout the nation, doctors continue to battle this virus. In this environment of fear and death, a most unlikely tool has surfaced in the maelstrom, giving hope and life in a most desperate time.
What is showing efficacy
? Nebulized budesonide.
The Food and Drug Administration (FDA) granted emergency use authorizations (EUAs) for PCR tests, monoclonal antibodies, and vaccines. It is time to add a new weapon in this war and grant a similar EUA for this effective, inexpensive and widely available, therapy that has been FDA-approved for other purposes for over four decades.
What is budesonide?
Budesonide has been utilized for over 40 years to help treat and prevent the symptoms of asthma in even our most vulnerable members of society – premature infants. The Mayo Clinic states that budesonide “is used to help prevent the symptoms of asthma.” According to WebMD, budesonide “is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This medication belongs to a class of drugs known as corticosteroids. It works directly in the lungs to make breathing easier by reducing the irritation and swelling of the airways.”